This effect is due to ERβ action on target genes, which include the ones involved in Wnt/β-catenin pathway (DKK1, WNT4, and CDH1) and in G1/S cell cycle checkpoint control (CDKN1A), two signaling pathways well-known for their role in cancer cell proliferation [108,109]. Here, ESR2 is linked to cancer.